MultivisionDx

Spatial biology for personalized medicine

MultivisionDx builds AI-powered decision-support tools for personalized diagnosis and treatment selection for solid cancer. Our computer vision technology integrates unique biological and spatial features of the tumor and its microenvironment, generating patient-specific tumor profiles for each patient.

This approach allows clinicians to assess tumor aggressiveness and tailor the most effective treatment strategies for individual patients.

Milestones

Header

MultivisionDx builds AI-powered decision-support tools for personalized diagnosis and treatment selection for solid cancer. Our computer vision technology integrates unique biological and spatial features of the tumor and its microenvironment, generating patient-specific tumor profiles for each patient.

This approach allows clinicians to assess tumor aggressiveness and tailor the most effective treatment strategies for individual patients.

Dec/25

1M Pre-seed funding round

MultivisionDx announces its first VC funding to accelerate development

Oct/25

Medix Prize

MultivisionDx proof-of-concept named top biomedical study in Finland

April/25

Company launched

MultivisionDx launches as a spinout from the University of Helsinki following a successful Research-to-Business project

Oct/24

Publication in Cell

Proof-of-concept in 650 head-and-neck cancer patients published in top scientific journal
Jan/23

Launch of MultivisionDx project

Supported by University of Helsinki and Business Finland

Nov/22

Secured €680k Business Finland funding

Research to Business funding granted for two year commercialization project